Sort: by Relevance
Relevance
Date
Filter: by Year
All Years
2026
2025
2024
2023
2022
2021
Earlier
Invest Europe welcomes the EU’s ambition to lead on regulation on artificial intelligence. In order to ensure that the AI sector can continue to thrive, Invest Europe calls on the EU negotiating parties on the AI Act to ensure that there are no barriers to investment, trade, and innovation.
Positions & consultation responses
Invest Europe has written to EU leaders and relevant finance ministers on the EU response to the United States' Inflation Reduction Act (IRA) ahead of the European Council meeting on 23/24 March. The EU response to the IRA should be considered as an opportunity to improve the EU investment landscape in order to allow European companies to thrive globally, without having to leave the bloc.
Positions & consultation responses
EuropeanIssuers, the European Banking Federation and Invest Europe join forces to kindly request the European Commission an extension of the deadline for the consultation on the EU Listing Act, in line with the delays that have been approved for other CMU files. This would allow the industry to delivery a more thorough and data-driven response.
Positions & consultation responses
Member Only
The survey was taken in the middle of 2024 against a backdrop of geopolitical tensions and challenging economic conditions. It reveals how wealth advisers are adapting to an evolving landscape, with insights on sentiment, private markets, AI, and intergenerational wealth transfer.
External resources
Member Only
During this first leg of our new webinar series we covered the basics of AI from a private equity and venture capital perspective.
Webinars
A comprehensive and practical set of guidelines encompassing best practices for investor reporting within the private equity industry.
The 2024 Invest Europe Investor Reporting Guidelines are also available as a standalone PDF document. Please download it here.
Member guides
A comprehensive and up-to-date set of standards and guidelines for the private equity industry.
Member guides
Europe stands at a crossroads for biotech and healthcare, as it continues to lose companies, capital, talent and clinical activity to more competitive ecosystems abroad. The European Biotech Act I’s delivery must be comprehensive and future-proof. Invest Europe’s position sets out how the Act can become a true end‑to‑end ecosystem strategy. Without addressing remaining structural bottlenecks, Europe risks continued underperformance in a sector that is central to competitiveness, health security and strategic autonomy.
Positions & consultation responses
Member Only
AI is becoming increasingly common in business practices, generating significant opportunities as well as material risks across sectors and therefore investment portfolios. Railpen's report, in collaboration with Chronos Sustainability, contains actionable recommendations to help investors move from theory to practice on responsible AI.
External resources
Member Only
Arthur D. Little: The potential of AI is vast, but its true impact often lies not in the technology itself, but in the people who wield it. Success requires balancing technical mastery with a broader ability to integrate knowledge and systems. It also calls for a cultural shift — one that fosters collaboration, trust, and a willingness to reimagine traditional approaches. The report is not intended to be just as an analysis, but also an invitation to take action.
External resources